Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Yi-le Yang, Qi-yue Wang, Yong-qiang Zhou, Xin-ying Zhang, Zhuo-bin Chen, Yong Liu et al. Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy. // Acta Pharmacologica Sinica. – 2026. – DOI: 10.1038/s41401-026-01958-8. – URL: https://www.nature.com/articles/s41401-026-01958-8
Yi-le Yang, Qi-yue Wang, Yong-qiang Zhou, Xin-ying Zhang, Zhuo-bin Chen, Yong Liu, Yao-hua Hu, Jun-wen Wang, & Jing Qin (2026). Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy. Acta Pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01958-8
Yi-le Yang, et al. “Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy.” Acta Pharmacologica Sinica, 2026. doi:10.1038/s41401-026-01958-8.
@article{Yang2026,
title = {Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy},
author = {Yang, Yi-le and Wang, Qi-yue and Zhou, Yong-qiang and Zhang, Xin-ying and Chen, Zhuo-bin and Liu, Yong and Hu, Yao-hua and Wang, Jun-wen and Qin, Jing},
journal = {Acta Pharmacologica Sinica},
year = {2026},
doi = {10.1038/s41401-026-01958-8},
url = {https://www.nature.com/articles/s41401-026-01958-8}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/s41573-026-01583-4 From hope to adoption: an industry perspective on the maturation of new approach methodologies